Related references
Note: Only part of the references are listed.Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis et al.
CANCER RESEARCH (2010)
Measles Virus Selectively Blind to Signaling Lymphocytic Activation Molecule (SLAM; CD150) Is Attenuated and Induces Strong Adaptive Immune Responses in Rhesus Monkeys
Vincent H. J. Leonard et al.
JOURNAL OF VIROLOGY (2010)
Intelligent Design: Combination Therapy With Oncolytic Viruses
Kathryn Ottolino-Perry et al.
MOLECULAR THERAPY (2010)
A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1954
Prashant Patel et al.
MOLECULAR THERAPY (2009)
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam et al.
BLOOD (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo
M. Wang et al.
LEUKEMIA (2008)
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide
R. M. Myers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Lymphoma chemovirotherapy: CD20-Targeted and ConvertaseArmed measles virus can synergize with fludarabine
Guy Ungerechts et al.
CANCER RESEARCH (2007)
An immunocompetent murine model for oncolysis with an armed and targeted measles virus
Guy Ungerechts et al.
MOLECULAR THERAPY (2007)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses
Giulia Fulci et al.
CANCER RESEARCH (2007)
Coadministration of a herpes simplex virus-2-based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses
Hongtao Li et al.
CANCER RESEARCH (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Fludarabine in chronic lymphocytic leukaemia
Thomas Elter et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses
NC Di Paolo et al.
CANCER RESEARCH (2006)
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells
L Heinzerling et al.
BLOOD (2005)
Current treatment approaches for mantle-cell lymphoma
TE Witzig
JOURNAL OF CLINICAL ONCOLOGY (2005)
Envelope targeting:: Hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism
C Springfeld et al.
JOURNAL OF VIROLOGY (2005)
Kaposi's sarcoma -: Associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling
TG Seo et al.
CANCER RESEARCH (2005)
Rescue and propagation of fully retargeted oncolytic measles viruses
T Nakamura et al.
NATURE BIOTECHNOLOGY (2005)
Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model
S Vongpunsawad et al.
JOURNAL OF VIROLOGY (2004)
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia
H Schulz et al.
BLOOD (2002)
Efficiency of measles virus entry and dissemination through different receptors
U Schneider et al.
JOURNAL OF VIROLOGY (2002)
Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells
ZA Nagy et al.
NATURE MEDICINE (2002)
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
NF Rose et al.
CELL (2001)
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity
V von Messling et al.
JOURNAL OF VIROLOGY (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
Share Paper
